Deal Announcements

Neurovance Raises $3 Million Venture Equity

Wednesday, April 02, 2014 5:53:00 AM PDT | VentureDeal

Cambridge, Massachusetts  --  Pharmaceutical technology company Neurovance (no website) has received $3 million in venture capital investment, according to an SEC regulatory filing.

Neurovance is a stealth stage company that is developing pharmaceutical preparations for the treatment of central nervous system disorders.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Neurovance is still seeking $3.3 million in additional financing, according to the filing, in minimum investment sizes of $16,345.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1